In Logsdon’s datasets, S100A4 was found to be higher expressed in pancreatitis (fold change = 2.57), and pancreatic adenocarcinoma (fold change = 4.44) versus normal tissues. This evidence concerns the gene S100A4 and pancreatic adenocarcinoma.